BOLD
Price
$1.02
Change
-$0.05 (-4.67%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
23.95M
52 days until earnings call
PRME
Price
$2.42
Change
-$0.24 (-9.06%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
347.93M
40 days until earnings call
Interact to see
Advertisement

BOLD vs PRME

Header iconBOLD vs PRME Comparison
Open Charts BOLD vs PRMEBanner chart's image
Boundless Bio
Price$1.02
Change-$0.05 (-4.67%)
Volume$7.7K
Capitalization23.95M
Prime Medicine
Price$2.42
Change-$0.24 (-9.06%)
Volume$19.36K
Capitalization347.93M
BOLD vs PRME Comparison Chart in %
Loading...
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BOLD vs. PRME commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOLD is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (BOLD: $1.07 vs. PRME: $2.65)
Brand notoriety: BOLD and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BOLD: 259% vs. PRME: 106%
Market capitalization -- BOLD: $23.95M vs. PRME: $347.93M
BOLD [@Biotechnology] is valued at $23.95M. PRME’s [@Biotechnology] market capitalization is $347.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BOLD’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • BOLD’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than BOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BOLD’s TA Score shows that 5 TA indicator(s) are bullish while PRME’s TA Score has 6 bullish TA indicator(s).

  • BOLD’s TA Score: 5 bullish, 4 bearish.
  • PRME’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRME is a better buy in the short-term than BOLD.

Price Growth

BOLD (@Biotechnology) experienced а +2.88% price change this week, while PRME (@Biotechnology) price change was +47.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.46%. For the same industry, the average monthly price growth was +36.24%, and the average quarterly price growth was +15.15%.

Reported Earning Dates

BOLD is expected to report earnings on Aug 18, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($348M) has a higher market cap than BOLD($24M). PRME YTD gains are higher at: -9.247 vs. BOLD (-63.103). BOLD has higher annual earnings (EBITDA): -72.59M vs. PRME (-200M). PRME (144M) and BOLD (138M) have equal amount of cash in the bank . BOLD has less debt than PRME: BOLD (48.6M) vs PRME (121M). PRME has higher revenues than BOLD: PRME (3.85M) vs BOLD (0).
BOLDPRMEBOLD / PRME
Capitalization24M348M7%
EBITDA-72.59M-200M36%
Gain YTD-63.103-9.247682%
P/E Ratio0.14N/A-
Revenue03.85M-
Total Cash138M144M96%
Total Debt48.6M121M40%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BOLDPRME
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRIS2.220.05
+2.30%
Curis
NCDL16.590.29
+1.78%
Nuveen Churchill Direct Lending Corp
ANSS343.401.71
+0.50%
ANSYS
PRQR2.16N/A
N/A
ProQR Therapeutics NV
GPI433.52-8.44
-1.91%
Group 1 Automotive

BOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, BOLD has been loosely correlated with XOMA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BOLD jumps, then XOMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLD
1D Price
Change %
BOLD100%
N/A
XOMA - BOLD
35%
Loosely correlated
-0.47%
DSGN - BOLD
34%
Loosely correlated
-3.29%
PRME - BOLD
33%
Poorly correlated
+9.50%
OVID - BOLD
33%
Poorly correlated
+9.06%
INBX - BOLD
33%
Poorly correlated
-0.80%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+9.50%
CRSP - PRME
63%
Loosely correlated
-0.17%
RXRX - PRME
57%
Loosely correlated
+4.65%
BEAM - PRME
57%
Loosely correlated
+2.27%
CRBU - PRME
53%
Loosely correlated
-4.93%
CCCC - PRME
50%
Loosely correlated
-1.30%
More